World's First Cardiac Adult Stem Cell Patient Receives Infusion
Trial taking place in Louisville, KY
LOUISVILLE, Ky., July 24 /PRNewswire-USNewswire/ -- Michael (Mike) Jones has become the world's first recipient of adult cardiac stem
cells to treat congestive heart failure. Jones' infusion on July 17 marks the world's first phase-one...
Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy
SUNRISE, Fla., July 7 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT) announced today that the panel discussion on myoblast (muscle stem
cell) therapy between distinguished physicians and scientists is available for playback at the following site:
UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
PITTSBURGH, Pennsylvania, and JERUSALEM, Israel, June 15 /PRNewswire/ --
The University of Pittsburgh Cancer Institute (UPCI) and the Gamida Cell -
Teva Joint Venture announced today that the Institute has joined an elite
group of cancer centers in Europe, the United States and Israel that a...
Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries Stem
Cell Technologies for Surgery
TEXARKANA, Texas, June 5 /PRNewswire/ -- A new breakthrough in adult stem
cell technology has three Texarkana neurosurgeons leading their industry by utilizing concentrated stem
cells for spine surgery. The innovative technique is improving the desired resul...
Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
IRVINE, Calif., June 4 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP) the market leader in laser transmyocardial revascularization (TMR) for the treatment of chronic cardiac ischemia, announces that Dr. Naresh Trehan of New Delhi will be presenting his clinical results of ...
Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support
Small Molecule Stem
Cell Modulator Administered in Dual Cord Blood Transplant for Hematologic Malignancy
LA JOLLA, Calif., May 27 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that the first patient has been treated in a Phase 1b clinical trial of FT1050, a small molecule Stem
New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
NIH Should Fix Standards to Allow Use of Current Stem
SANTA MONICA, Calif., May 20 /PRNewswire-USNewswire/ -- -- Regulations governing stem
cell research proposed by the Obama Administration -- unless modified before final implementation on July 1 -- prohibit federal fund...
BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
ARLINGTON, Va., May 5 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, Capitalizing on New Opportunities for Stem
Cell Products. Despite a sluggish economy and cuts being made to laboratory budgets, the market for stem
cell research products is expected to increa...
Discovery of Marker for Colon Stem Cells Could Shed Light on What Drives Tumor Growth
WILMINGTON, Del., April 7 /PRNewswire/ -- Cancer researchers led by Bruce Boman, M.D., Ph.D. director of Cancer Genetics and Stem
Cell Biology at the Helen F. Graham Cancer Center of the Christiana Care Health System, and a faculty member at the University of Delaware , have discovered an enzyme ...
Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
SAN DIEGO, March 27 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) today reported on an NIH-funded, pre-clinical study conducted by independent researchers at the University of Cincinnati entitled IGF-1--Overexpressing Mesenchymal Stem
Cells Accelerate Bone Marrow Stem
MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
WOONSOCKET, R.I., March 19 /PRNewswire-FirstCall/ --MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announced today that it has entered into a cooperative research and development agreement with Maxim Biotech, Inc. to develop products for the study of liver stem
cells and liver cancer.
Roundtable Calls President's Embryonic Stem Cell Decision: Bankrupt
CLEVELAND, March 9 /PRNewswire-USNewswire/ -- In response to the President's actions today changing federal policy on embryonic stem
cell research, David Zanotti, CEO of the American Policy Roundtable and Dr. Charles McGowen, M.D., Chief Medical Advisor for the Roundtable, issued the following sta...
Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
Make Synaptic Contact with Host Motor Neurons
ROCKVILLE, Md., March 9 /PRNewswire-FirstCall/ -- Transplanted human neural stem
cells (hNSCs) developed by Neuralstem, Inc. (NYSE Alternext US: CUR) made synaptic contacts with the motor neurons of rats with ALS-like symptoms, a paper published i...
New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds
SAN FRANCISCO, March 5 /PRNewswire-USNewswire/ -- Scleroderma is an autoimmune disease that leads to thickening and severe scarring of skin as well as thickening and failure of internal organs, including the lungs, heart, kidneys and intestines. The disease -- which the Scleroderma Foundation esti...
Michigan Catholic Conference Welcomes Announcement of Non-Embryo Destructive Stem Cell Research Advancement
LANSING, Mich., March 2 /PRNewswire-USNewswire/ -- Michigan Catholic Conference Vice President for Public Policy Paul Long made the following statement today regarding a study in the online journal Nature, and reported in today's Washington Post, that stem
cell researchers have discovered an addit...
Wayne County Partners With TechTown to Launch Global Stem Cell 'Innovation and Commercialization Lab'
2,500-square-foot 'open lab' will serve as international hub for collaborative research, biotech start-ups
DETROIT, Feb. 16 /PRNewswire-USNewswire/ -- TechTown, the Wayne State University research and technology park, will soon be home to the first stem
cell commercialization lab in Michiga...
Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinson's Disease
LOS ANGELES, Feb. 16 /PRNewswire/ -- Scientists announced today the
publication of a landmark peer-reviewed paper in the February issue of the
Bentham Open Stem
Cell Journal which outlines the long term results of the
world's first clinical trial using autologous neural stem
cells for the
FDA Stem Cell Approval Breakthrough Laudable
SAN CLEMENTE, Calif., Jan. 23 /PRNewswire/ -- Today the FDA announced
approval for the first clinical trials on humans using Embryonic Stem
but Adult Stem
Cell scientist Christian Drapeau says the experts may not be
telling the whole story; Adult Stem
Cells have greater potential with le...
UK Must Maintain its Momentum in Stem Cell Expertise
LONDON, January 19 /PRNewswire/ -- Excalibur, the international
investment house specialising in medical sciences, said today the UK must
'maintain its momentum' to deliver pioneering stem
cell treatments if it is
to remain at the forefront of medical technology.
Professor Sir Christoph...
Gene Marker May Improve Odds of Stem Cell Therapies for Disease
PHILADELPHIA, Jan. 9 /PRNewswire-USNewswire/ -- A single tumor-suppressor gene may provide a unique marker for senescence in Mesenchymal stem
cells (MSCs) in vitro, while also playing a role in moving MSCs into senescence, researchers at the Human Health Foundation and the Sbarro Institute for Can...
Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source
St. Jude scientists show for the first time that normal stem
cells can act as the source of tumors in mature solid tissues
MEMPHIS, Tenn., Dec. 17 /PRNewswire-USNewswire/ -- Scientists at St. Jude Children's Research Hospital have answered a central question in cancer biology: whether n...
Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes
SAN FRANCISCO, Dec. 7 /PRNewswire-USNewswire/ -- Two studies examining the effects of stem
cell source and patient age on stem
cell transplantation outcomes will be explored at a press conference taking place on Sunday, December 7, at 8:00 a.m., during the 50th Annual Meeting of the American Socie...
Open Letter to President-Elect Barack Obama From Don Margolis, Chairman and Founder of The Repair Stem Cell Institute
WASHINGTON, Nov. 24 /PRNewswire-USNewswire/ --
Dear President-Elect Obama:
Your first four year Presidential term will start with billions of dollars
earmarked for stem
cell research. As spokesman for the Repair Stem
Institute (RSCI), which is the voice of the Repair Stem
Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology
- Technology In-Licensed by Stem
Cell Sciences From University of Cambridge - ("Stem Cell Sciences", "SCS", "the Company")
CAMBRIDGE, England, Oct. 24 /PRNewswire/ -- Stem
Cell Sciences plc
(AIM: STEM, ASX: STC), a company focused on the commercialisation of stem
cells and stem
Consumer Group Urges Gov. Schwarzenegger to Sign Stem Cell Bill Into Law
SANTA MONICA, Calif., Sept. 15 /PRNewswire-USNewswire/ -- Gov. Arnold
Schwarzenegger should sign a stem
cell public accountability bill, SB1565,
into law, Consumer Watchdog said today. The bill, sponsored by Sen. Sheila
Kuehl and Sen. George Runner, was passed with overwhelming bipartisan
Stem Cell Sciences Announces the Creation of the World's First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
CAMBRIDGE, England, September 2 /PRNewswire-FirstCall/ --
- ("Stem Cell Sciences", "SCS", "the Company")
Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the
commercialisation of stem
cells and stem
cell technologies, is pleased to
announce that two independent laboratories...
DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties
Spraying Set for Tonight in Parts of Bucks, Delaware, Montgomery,
NORRISTOWN, Pa., Aug. 27 /PRNewswire-USNewswire/ -- After encouraging
results following the first night of aerial treatments, the Department of
Environmental Protection will continue its efforts this eveni...
CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance
A Complimentary Continuing Education Activity
VOORHEES, N.J., Aug. 14 /PRNewswire/ -- Cytomegalovirus (CMV) is a
significant cause of morbidity and mortality in recipients of hematopoietic
stem cell transplantation. The clinical manifestations of CMV disease are
serious and range ...
Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells
ASPS Study Finds Some Areas of the Body Have Greater Concentrations of
ARLINGTON HEIGHTS, Ill., July 23 /PRNewswire-USNewswire/ -- Fat removed
from the lower abdomen and inner thigh through liposuction was found to be
an excellent source of stem
cells, with higher stem
Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
IRVINE, Calif., June 12 /PRNewswire-FirstCall/ -- Cardiogenesis
Corporation (Pink Sheets: CGCP), a leading developer of surgical products
for cardiac revascularization, today announced a scientific presentation
that describes the use of the PHOENIX delivery system combining
Brain Stem Cells Can Be Awakened, Say Schepens Scientists
Study Findings Promise to help in treatment of brain diseases
BOSTON, June 6 /PRNewswire/ -- Scientists at Schepens Eye Research
Institute have identified specific molecules in the brain that are
responsible for awakening and putting to sleep brain stem
when activated, can t...
ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
- Phase 3 Study in 681 Stem
Cell Transplant Patients Represents First
Pivotal Study on a New Antiviral CMV Therapy in Stem
Cell Transplant in Over a Decade -
- Company Also Provides Timing of Phase 3 Data Disclosure and Regulatory Submi...
California Stem Cell Agency Exaggerated Its Role in Funding Key Research
Agency Claimed State Funding Led to Important Clinical Trials
SANTA MONICA, Calif., April 16 /PRNewswire-USNewswire/ -- California's
stem cell agency overstated and hyped the importance of its funding in
enabling clinical trials for a drug to treat a severe blood disorder,
Texas Heart(R) Institute at St. Luke's Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
HOUSTON, April 14 /PRNewswire-USNewswire/ -- Physician scientists at
the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital announced
they have begun the world's first clinical trial to treat heart attack
patients with a special type of stem
cell to promote better healing and to
Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico
MONTERREY, Mexico, March 20 /PRNewswire/ -- Optimum Health Regeneration
Center announced the successful treatment of an American family treated for
pain management and impaired mobility. This New Mexico family, ranging in
age from 52 to 78, all recorded significant improvements in reduced pain...
NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit
Multiple Clinical Applications for Blood-Derived Stem
Cells and Strong Industry Outlook Support NeoStem's Business Model
NEW YORK, Feb. 28 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS ),
which is pioneering the pre-disease collection, processing and long-term
storage of adult...
SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
AUSTIN, Texas, Feb. 25 /PRNewswire/ -- SpineSmith Partners, LP, a
biotech medical device company that focuses on new treatments for spinal
disorders, announced today that Dr. Robert G. Johnson, MD, and Dr. Stuart
Williams, PhD, are scheduled to present at the 3rd Annual Stem
A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
WASHINGTON, Feb. 12 /PRNewswire-USNewswire/ -- A new study demonstrates
for the first time that embryonic stem
cells can be used to create
functional immune system blood cells, a finding which is an important step
in the utilization of embryonic stem
cells as an alternative source of
Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells
Appoints U.S. Biotest to Oversee Trials
PRINCETON, N.J., Jan. 24 /PRNewswire-FirstCall/ -- Derma Sciences, Inc.
(OTC Bulletin Board: DSCI), a provider of advanced wound care products,
announced today that it has signed a clinical services agreement with San
Luis Obispo-based, p...
New Conflict of Interest Violations Revealed at California Stem Cell Institute
Tainted Research Grant Applications Must Be Rejected, Consumer
SANTA MONICA, Calif., Dec. 7 /PRNewswire-USNewswire/ -- More apparent
conflict of interest violations in applications for research grants in
California's $6 billion stem
cell program were revealed today and the